"GENESIS 26 is exceptionally timely because it brings together the exact ingredients needed for real impact: cutting-edge research in bioengineering and AI, strong technology and industry partners, and a shared commitment to translation."

"The combination of academia, industry, and technology providers is exactly what we need to push OoC technologies forward. This field is rapidly evolving, and collaboration is essential to overcoming the current challenges, such as scalability, standardization, and technology transfer. iL’s infrastructure provides an ideal environment to foster such collaborations."

"The LSTD is a high-quality series of events, and I am looking forward to seeing exciting technologies again. For me, it's about translating scientific and technical excellence into practical applications that benefit patients."